ROCK1 and Hepatic fibrosis: In RhoA-inhibited liver fibrotic mice, the levels of serum indicators and the expression of liver fibrosis-related factors also declined to a certain degree, indicating that the RhoA/ROCK1 signalling pathway plays a role in improving liver fibrosis and that intervention with RhoA can alleviate the progression of liver fibrosis.